Orthopedic surgeon named Reinvent Biologics’ CMO: 3 insights

Reinvent Biologics appointed orthopedic surgeon David Drez Jr., MD, as CMO.

Advertisement

Here are three things to know:

1. Dr. Drez serves as a senior adviser at Lake Charles, La.-based Imperial Health Center for Orthopaedics. He co-authored Orthopedic Sports Medicine and co-edited Operative Techniques in Sports Medicine.

2. As CMO, Dr. Drez will provide strategic leadership for the regenerative medicine company’s education and research activities, train medical professionals and serve as a resource on Reinvent’s sales efforts.

3. Dr. Drez has more than 42 years of experience in orthopedics and sports medicine.

More articles on biologics:
Human skeletal stem cells identified, may have therapeutic potential: 4 things to know
Dr. Pablo Pazmino: Key thoughts on stem cells & new technology in spine surgery
Orthopedic surgeon performs case in Pluristem Therapeutics’ stem cell trial: 4 insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.